Takip et
Dr. Abhinav Anand
Dr. Abhinav Anand
CT Institute of Pharmaceutical Sciences
apsecr.org üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review
A Anand, AA Patience, N Sharma, N Khurana
European journal of pharmacology 815, 364-375, 2017
2132017
Vanillin: A comprehensive review of pharmacological activities
A Anand, R Khurana, N Wahal, S Mahajan, M Mehta, S Satija, N Sharma, ...
Plant Arch 19 (2), 1000-1004, 2019
452019
Pharmacological Management of Alzheimer’s Disease
NK Rakesh Kumar, Rajan Kumar, Abhinav Anand, Neha Sharma
Advances in Neuropharmacology Drugs and Therapeutics, 133-150, 2020
33*2020
Emerging treatments for the behavioral and psychological symptoms of dementia
A Anand, P Khurana, J Chawla, N Sharma, N Khurana
CNS spectrums 23 (6), 361-369, 2018
332018
PREDICTION OF ACTIVITY SPECTRA OF SUBSTANCES ASSISTED PREDICTION OF BIOLOGICAL ACTIVITY SPECTRA OF POTENTIAL ANTI-ALZHEIMER’S PHYTOCONSTITUENTS
A Anand, N Sharma, N Khurana
Asian Journal of Pharmaceutical and Clinical Research 10 (16), 13-21, 2017
222017
Therapeutic potential of epigallocatechin gallate
A Anand, J Chawla, A Mahajan, N Sharma, N Khurana
International Journal of Green Pharmacy (IJGP) 11 (03), 2017
162017
Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model
A Anand, N Khurana, N Ali, AF AlAsmari, M Alharbi, M Waseem, ...
Frontiers in Neuroscience 16, 1005972, 2022
112022
Prediction of anti-parkinson potential of phytoconstituents using prediction of activity spectra of substances software
R Kumar, R Kumar, A Anand, N Sharma, N Khurana
Asian Journal of Pharmaceutical and Clinical Research, 48-56, 2018
112018
The multifactorial role of vanillin in amelioration of aluminium chloride and D-galactose induced Alzheimer's disease in mice
A Anand, N Khurana, S Kaur, N Ali, AF AlAsmari, M Waseem, M Iqbal, ...
European Journal of Pharmacology 954, 175832, 2023
102023
Food for the mind: The journey of probiotics from foods to anti-Alzheimer’s disease therapeutics
A Anand, N Khurana, R Kumar, N Sharma
Food Bioscience, 102323, 2022
62022
Trash to treasure: advancing resource efficiency using waste-derived fillers as sustainable reinforcing agents in bioplastics
Z Tabassum, M Girdhar, A Anand, N Kumari, B Sood, T Malik, A Kumar, ...
Materials Advances 6 (2), 527-546, 2025
22025
Amyloid beta: the foremost protagonist in alzheimer's disease
A Anand, N Sharma, M Gulati, N Khurana
Handbook of Research on Critical Examinations of Neurodegenerative Disorders …, 2019
22019
Identification of molecular targets of potential antidiabetic drugs using prediction of activity spectra for substances and molecular docking
MN Sharma
International Journal of Green Pharmacy (IJGP) 12 (02), 2018
22018
Quantification of the SARS-CoV-2 RNA in Tissues by Quantitative Real Time-PCR
A Anand, N Sharma, S Bajaj, N Wahal, D Tewari, N Khurana
Coronavirus Disease-19 (COVID-19): A Perspective of New Scenario 1, 273, 2021
2021
THE RELATIONSHIP OF MAGNOLOL, AN IMPORTANT PHYTOCONSTITUENT, WITH NEUROLOGICAL DISORDERS: An In silico EVALUATION
A ANAND, V BABU, R GIRIYAM, S TURAN, N SHARMA, N KHURANA, ...
PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY 22 (35-36), 388-396, 2021
2021
An analysis of human immunodeficiency virus/acquired immune deficiency syndrome-related awareness among masses
A Anand, RR Patyar, SSK Dargan, S Patyar
International Journal of Basic & Clinical Pharmacology 4 (4), 678, 2015
2015
Potential of Prediction of Activity Spectra of Substances Software to Justify 3Rs
R Kumar, R Kumar, A Anand, R Mahajan, GL Khatik, N Duggal, M Mehta, ...
Evaluation of Nephroprotective Activity
K Manshare, A Anand, S Mahajan, S Satija, N Sharma, N Khurana, ...
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–18